LPL Financial’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $292K | Buy |
75,493
+8,912
| +13% | +$34.5K | ﹤0.01% | 4682 |
|
|
2025
Q1 | $333K | Buy |
66,581
+8,408
| +14% | +$42K | ﹤0.01% | 4411 |
|
|
2024
Q4 | $419K | Buy |
58,173
+7,693
| +15% | +$55.5K | ﹤0.01% | 4169 |
|
|
2024
Q3 | $310K | Sell |
50,480
-1,182
| -2% | -$7.26K | ﹤0.01% | 4321 |
|
|
2024
Q2 | $344K | Sell |
51,662
-1,767
| -3% | -$11.8K | ﹤0.01% | 4091 |
|
|
2024
Q1 | $544K | Buy |
53,429
+18,987
| +55% | +$193K | ﹤0.01% | 3661 |
|
|
2023
Q4 | $387K | Buy |
+34,442
| New | +$387K | ﹤0.01% | 3825 |
|
|
2016
Q2 | – | Sell |
-33
| Closed | -$21K | – | 2634 |
|
|
2016
Q1 | $21K | Buy |
+33
| New | +$21K | ﹤0.01% | 3056 |
|